MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 02, 2017 -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq:RWLK) today announced that Larry Jasinski, Chief Executive Officer, will present at the Canaccord Genuity Growth Conference 2017 in Boston as follows:
| Date: | Wednesday, August 9, 2017 |
| Time: | 5:00 PM Eastern Daylight Time |
The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Company’s website at: www.rewalk.com, under the Investors Section.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.
Contact: Lisa Wilson In-Site Communications, Inc. Investor Relations T: (212) 452-2793 E: [email protected]


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Italy Fines Apple €98.6 Million Over App Store Dominance
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



